Objectives: A primary goal following lower limb amputation is to maximize patient quality of life (QoL) and satisfaction (SAT) with health. For those individuals that are candidates for prostheses, mobility (MOB) is also considered a primary goal. The role of the prosthesis in improving QoL and SAT is not well known. The purpose of this study was to examine the QoL, SAT, and MOB in a cross-sectional analysis of individuals with lower limb amputation owing to diabetes/vascular disease at various periods post amputation with and without a prosthesis.
Methods: Retrospective cross-sectional study of 761 patients with major lower limb amputation owing to vascular disease/diabetes (age,61.1 6 11.1 years; height, 174.6 6 10.6 cm; weight, 90.0 6 25.0 kg). Individuals were grouped according to whether they had a prosthesis and elapsed time since amputation (from 0 to 3 months up to 61-84 months). QoL and SAT were analyzed as separate elements of the validated Prosthesis Evaluation Questionnaire Well Being (PEQ-WB) in addition to the PEQ-WB composite score. MOB was calculated from the validated Prosthetic Limb Users Survey of Mobility (PLUS-M). Groups were compared through separate one-way analysis of variance with Fishers least squares difference post hoc tests. Study oversight was provided by the Western Institutional Review Board.
Results: Group sizes averaged 57 in the 6 prosthesis cohorts and 208 in the two no-prosthesis cohorts. Significant differences were found for QOL (F7,750 ¼ 3.558; P ¼ .001), SAT (F7,747 ¼ 3.223; P ¼ .002), and PEQ-WB score (F7,753 ¼ 3.297; P ¼ .002). Post hoc tests showed QOL, SAT and PEQ-WB scores were increased for patients with a prosthesis (P < .05), and that the scores for these individuals remained higher than scores reported by those without a prosthesis extending out as far as 61 to 84 months postamputation (Fig 1) . There were no significant differences for mobility among prosthesis users (F6, 368 ¼ 1.347; P ¼ .235; Fig 2) .
Conclusions: As time since amputation progresses without a prosthesis, QOL and SAT decrease for patients with amputation owing to vascular disease/diabetes. For individuals with a prosthesis, there is an initially elevated QOL and SAT, which then declines modestly and subsequently plateaus. Of note, QOL remained significantly greater than what is reported by those without a prosthesis at 4 to 6 months after amputation. Furthermore, mobility with a prosthesis is consistent throughout all examined periods, extending as far as 61 to 84 months after amputation with no reported decline across groups. Future work should investigate these effects through longitudinal analysis. Objectives: Several studies have demonstrated socioeconomic status affects surgical outcomes, however analyses in vascular surgery are limited. We sought to determine if the Distressed Communities Index (DCI), a composite socioeconomic score by zip code, could predict short and long-term outcomes after infrainguinal bypass.
Methods: Data on all VQI patients (N ¼ 2578) undergoing infrainguinal bypass (2011-2017) within a region of 17 centers were paired with the DCI scores. The metric was developed by the Economic Innovation Group and is normally distributed from 0 (no distress) to 100 (severe distress), accounting for unemployment, education level, poverty rate, median income, business growth, and housing vacancies. Patients were stratified by distressed (top DCI quartile) versus not for univariate analysis. Hierarchical regression assessed short-term outcomes and time-to-event analyses assessed long-term results.
Results: Infrainguinal bypass patients come from disproportionately distressed communities, with 29% of patients living within the top DCI quartile (P < .0001). These patients are younger, more likely to smoke, disproportionately African American, and have higher rates of medical comorbidities (all P < .05). While distressed communities had an equivalent rate of major adverse cardiac and cerebrovascular events (5% vs 4%; P ¼ .86), they have increased rates of major adverse limb events (MALE) at 13% vs 10% (P ¼ .03). This trend persists in the long term with higher overall rate of MALE (36% vs 30%; P ¼ .045; Fig) as well as the components of amputation (18% vs 14%; P ¼ .006) and thrombectomy (11% vs 7%; P ¼ .002). Revision rates were similar (18% vs 17%; P ¼ .50). Distressed  Fig 1. Long-term outcomes following dysvascular/diabetic amputation. e212 Abstracts
Journal of Vascular Surgery
June 2018
